PHT-1
PT
Menu
Search

Sections

  • Home
  • News
  • Analysis
    • Features
    • Comment
    • Data Insights
    • Projects
  • Sectors
    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Disease
      • Oncology
      • Respiratory
  • Themes
    • Artificial Intelligence
    • Corporate Governance
    • Cloud
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19
  • Insights
    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content
  • Pricing and Market Access
  • Events
  • Reports
  • Awards & Rankings
  • Magazine

GlobalData

  • About us
  • Advertise With Us
  • Contact Us
  • Our Marketing Solutions
  • GlobalData Reports
  • Visit GlobalData

From Our Partners

  • Precision medicine and digital health innovation for disease diagnosis, care and treatment
  • Enabling process intensification in biopharma manufacturing
  • Specialty drug launch strategy and operations
  • The next chapter of clinical trial services
  • Future Pharma Services
  • Putting quality first in the pharma supply chain
  • Enabling better biopharmaceutical manufacturing
  • Pharmaceutical Grade Silicone Manufacturer
  • Maximising molecule potential
  • News
  • Analysis

    Sections

    • Features
    • Comment
    • Data Insights
    • Projects

    Latest

    • Pharma Fix: The quest for the next tuberculosis vaccine
    • Pfizer acquires ADC pioneer Seagen for $43bn
    • Biotech’s post-IPO boom: rebounding from a 2022 Low?
  • Sectors

    Sections

    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area

    Latest

    • Alnylam’s Manufacturing Facility, Norton, Massachusetts
    • China’s NMPA grants conditional approval for AstraZeneca’s Calquence
    • Takeda set to build $764m manufacturing facility in Japan
  • Themes

    Sections

    • Artificial Intelligence
    • Cloud
    • Corporate Governance
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19

    Latest

    • Takeda set to build $764m manufacturing facility in Japan
    • Klinge Corporation
    • TRiBECA® Knowledge
  • Insights

    Sections

    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media

    Latest

    • Merck reports rise in group net sales in fiscal 2022
    • AbbVie reports rise in full-year 2022 net revenues
    • Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content

    Latest

    • Aseptic lyophilisation: Opportunities to improve quality and process monitoring with mass spectrometry
    • Optimising biopharma production through process intensification
    • Quality first: How pharma can meet injectables demand while staying compliant
  • Events
  • Reports
PT
  • Companies
Left
Right
  • Company A-Z
  • Company Categories
  • Products & Services
  • Company Releases
  • White Papers
  • Videos
  • Buyer’s Guides
  • Partner Content

Subscribed

You have successfully subscribed and will receive the next available issues

Introduction to BlueCielo

  • Videos

PharmaceuticalTechnology

The leading site for news and procurement in the pharmaceutical industry

  • About us
  • Advertise with us
  • Contact us
  • Editorial approach
  • Newsletters
  • Our marketing solutions
  • Privacy policy
  • Terms and conditions

Powered by Pharma Tech Logo

© Verdict Media Limited 2023

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.